Matthew Spraker, MD, PhD, has received a grant award from a private donation administered by the Goldman Sachs Foundation for his work entitled “LITE SABR M2: A phase II trial of palliative Lattice SBRT”. He will receive $156,628 over two years for his research.
Spraker receives grant
View Content